Status:
COMPLETED
A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays
Lead Sponsor:
GlaxoSmithKline
Conditions:
Infections, Streptococcal
Eligibility:
All Genders
65+ years
Brief Summary
GSK Biologicals is working on the development of a vaccine to protect elderly people from bacterial pneumonia. Diagnostic of bacterial pneumonia is difficult, and for the future studies in that projec...
Eligibility Criteria
Inclusion
- Subjects who the investigator believes that they can and will comply with the requirements of the protocol should be enrolled in the study.
- A male or female aged 65 or above at the time of the study.
- Written informed consent obtained from the subject.
- Clinical pneumonia diagnosed by chest X-ray detected within 7 days before study entry.
Exclusion
- Vaccination with a pneumococcal or Haemophilus vaccine within the last 3 months before study entry.
- Antibiotherapy started more than 7 days before Screening.
- A negative culture for Streptococcus pneumoniae or Non-Typable Haemophilus influenza.
- A urine sample at Screening less than 40 mL.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00637351
Start Date
March 1 2008
End Date
February 1 2009
Last Update
January 13 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Brussels, Belgium, 1200
2
GSK Investigational Site
Yvoir, Belgium, 5330